444 related articles for article (PubMed ID: 33618278)
21. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
22. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.
Khazir J; Maqbool T; Mir BA
Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800
[TBL] [Abstract][Full Text] [Related]
23. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
24. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
25. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.
Shagufta ; Ahmad I
Eur J Med Chem; 2021 Mar; 213():113157. PubMed ID: 33486200
[TBL] [Abstract][Full Text] [Related]
26. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.
Raman R; Patel KJ; Ranjan K
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356617
[TBL] [Abstract][Full Text] [Related]
27. Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19.
Bhattacharjee A; Saha M; Halder A; Debnath A; Mukherjee O
Curr Microbiol; 2021 Feb; 78(2):435-448. PubMed ID: 33392670
[TBL] [Abstract][Full Text] [Related]
28. A Therapeutic Journey of Potential Drugs Against COVID-19.
Ali F; Hussain S; Zhu YZ
Mini Rev Med Chem; 2022; 22(14):1876-1894. PubMed ID: 33845740
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.
Wang MY; Zhao R; Gao LJ; Gao XF; Wang DP; Cao JM
Front Cell Infect Microbiol; 2020; 10():587269. PubMed ID: 33324574
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
31. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
[TBL] [Abstract][Full Text] [Related]
32. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
33. An overview of potential therapeutic agents to treat COVID-19.
Dong X; Tian Z; Shen C; Zhao C
Biosci Trends; 2020 Nov; 14(5):318-327. PubMed ID: 33100290
[TBL] [Abstract][Full Text] [Related]
34. Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer.
Knight TE
Biopreserv Biobank; 2020 Dec; 18(6):492-502. PubMed ID: 32726140
[TBL] [Abstract][Full Text] [Related]
35. COVID-19: Progress in diagnostics, therapy and vaccination.
Liu X; Liu C; Liu G; Luo W; Xia N
Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
37. In-line treatments and clinical initiatives to fight against COVID-19 outbreak.
Agrawal M; Saraf S; Saraf S; Murty US; Kurundkar SB; Roy D; Joshi P; Sable D; Choudhary YK; Kesharwani P; Alexander A
Respir Med; 2022 Jan; 191():106192. PubMed ID: 33199136
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus.
Kouznetsov VV
Eur J Med Chem; 2020 Oct; 203():112647. PubMed ID: 32693298
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
Front Immunol; 2020; 11():569760. PubMed ID: 33362758
[TBL] [Abstract][Full Text] [Related]
40. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
